# The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

> **NCT03240328** · PHASE1 · RECRUITING · sponsor: **Guangzhou 8th People's Hospital** · enrollment: 40 (estimated)

## Conditions studied

- HIV/AIDS

## Interventions

- **BIOLOGICAL:** CAR-T cells

## Key facts

- **NCT ID:** NCT03240328
- **Lead sponsor:** Guangzhou 8th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-10-04
- **Primary completion:** 2023-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03240328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03240328, "The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03240328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*